Everything below concerns cyclic heptapeptide. We keep the language plain, cite what the science says, and separate well-supported claims from open questions.
Updated 2026-01-12. Numbers and descriptions here follow the published literature rather than marketing material.
Bremelanotide is a synthetic cyclic heptapeptide that acts on a family of G-protein-coupled receptors. It was designed as a structural analogue of alpha-melanocyte-stimulating hormone, the endogenous peptide associated with pigmentation and several central signalling pathways. A lactam bridge constrains the ring and slows enzymatic breakdown, which distinguishes it from the linear parent molecule. Research interest moved over time from pigment biology toward central nervous system effects, particularly circuits connected to sexual desire. Parenteral delivery is used because oral bioavailability is poor.
Early clinical work used an intranasal formulation, and later programmes switched to subcutaneous delivery for more consistent absorption. A subcutaneous product received regulatory approval in the United States in 2019 for premenopausal women with acquired, generalised hypoactive sexual desire disorder. Approval followed phase 3 trials in which active treatment separated from placebo on desire and distress measures, though the average difference was modest. Labeling carries a caution about transient blood pressure elevation, so cardiovascular history is assessed before prescribing. Questions about durability of benefit beyond several months remain open.
Published discussion sits at the intersection of peptide chemistry, neuroendocrinology and sexual medicine. Trial reports emphasise change scores on validated instruments, while mechanistic papers focus on hypothalamic circuits and receptor selectivity. Because placebo response in this field is large, effect sizes are usually reported with confidence intervals rather than as isolated averages. Reviews note that female and male data sets are not interchangeable and should be read separately. Diagnostic terminology has been revised over time, which complicates comparison between older and newer studies.
Lyophilized peptide material is generally stored at -20 °C or below to limit degradation, while reconstituted solutions are less stable and are typically kept refrigerated and protected from light. Repeated freeze-thaw cycles can accelerate aggregation and should be minimized. Stability for any specific lot depends on purity, moisture content, and packaging. Handling in a temperature-controlled environment reduces variability across replicates, and exposure to ambient humidity during weighing can introduce error. Aliquotting reduces the number of times a stock container is opened.
Reverse-phase high-performance liquid chromatography is the standard method for assessing purity. Mass spectrometry confirms molecular identity and detects sequence variants or truncation products. Ultraviolet absorbance at 214 or 280 nm is used for quantification, with the choice depending on the peptide sequence. Method validation typically addresses linearity, limit of detection, and precision across a defined concentration range. Impurity profiling may also employ ion-exchange or size-exclusion chromatography, and these techniques complement one another.
| Property | Value | Notes |
|---|---|---|
| Chemical class | Synthetic cyclic heptapeptide | Analogue of alpha-MSH |
| Molecular mass | Approximately 1025 Da | Peptide-scale molecule |
| Route | Subcutaneous injection | Intranasal form used in early research |
| Common synonyms | PT-141; bremelanotide acetate | Research code and salt form |
| Typical storage | 2-8 °C, protected from light | Unopened vial condition |
Melanocortin receptors form a family of five G-protein-coupled receptors designated MC1 through MC5. Bremelanotide binds most strongly at MC4R and MC1R, with weaker activity reported at MC3R and MC5R. MC4R is expressed in hypothalamic nuclei that coordinate energy balance and aspects of sexual behaviour. The prevailing interpretation is that central MC4R activation, rather than peripheral vascular effects alone, drives the reported changes in desire. This account remains partly inferential, since direct receptor-level measurement in living humans is not practical.
After subcutaneous administration, plasma concentrations rise within roughly thirty minutes and the elimination half-life is short, on the order of two to three hours. Reported physiological responses include transient increases in blood pressure and nausea, which tended to diminish with repeated dosing in trial settings. Because the peptide clears quickly, effects are not expected to persist long after a dose. Absorption from non-injected routes is poorly characterised, and nasal delivery produced variable plasma levels in older work.
PT-141 initiates cellular signaling by binding to specific subtypes within the melanocortin receptor family. These receptors belong to the G protein-coupled receptor superfamily, and activation raises intracellular cyclic adenosine monophosphate levels. This cascade ultimately influences neuronal circuits in the central nervous system that are associated with sexual desire and arousal. Research indicates the compound's action concentrates in hypothalamic regions rather than peripheral tissues, which helps explain some observed pharmacological features. The selectivity of receptor binding underlies its functional differences.
Compared with the related compound melanotan II, PT-141 shows markedly weaker activation of receptors tied to pigmentation. This difference stems from subtle structural variations that alter affinity distribution across receptor subtypes. Investigators propose that such selectivity produces a different side effect profile in specific applications. However, downstream consequences of prolonged receptor activation remain uncertain in the literature. Published studies do not fully agree on the duration of signaling pathway activity and the mechanisms of desensitization.
Clinical development proceeded through two routes of administration. An intranasal formulation advanced first, but variable absorption and tolerability problems led to a switch to subcutaneous injection. The United States Food and Drug Administration approved the subcutaneous product in 2019 for hypoactive sexual desire disorder in premenopausal women. Marketing rights subsequently changed hands, and commercial availability has fluctuated since approval. Use in men, in postmenopausal women, and in combination with other agents remains outside the approved label.
Outside the approved product, bremelanotide circulates as a research chemical sold by peptide vendors, often labelled PT-141. Such material is not manufactured under pharmaceutical quality standards, and independent testing has repeatedly found content that differs from the label. Analytical certificates supplied with a purchase are not strong evidence of purity because they are usually generated by the seller. Online discussion tends to blur the distinction between the approved drug and unregulated powder, which complicates interpretation of reported experiences.
=== Live data === Files that are actively being updated present a challenge to back up. One way to back up live data is to temporarily quiesce them (e.g., close all files), take a "snapshot", and then resume live operations. At this point the snapshot can be backed up through normal methods. A snapshot is an instantaneous function of some filesystems that presents a copy of the filesystem as if it were frozen at a specific point in time, often by a copy-on-write mechanism. Snapshotting a file while it is being changed results in a corrupted file that is unusable. This is also the case across interrelated files, as may be found in a conventional database or in applications such as Microsoft Exchange Server. The term fuzzy backup can be used to describe a backup of live data that looks like it ran correctly, but does not represent the state of the data at a single point in time. Backup options for data files that cannot be or are not quiesced include:
Although Tg2576 mice do not perfectly replicate late-stage AD with cell death, they do offer a platform for researching the physiology and biochemistry of the illness. With the help of transgenic mouse models, researchers can make progress in AD research by understanding the intricate relationships between gene products that are involved in the production of Aβ peptide.e physiology and biochemistry of the illness.
668,409 people were registered from administrative databases and could not declare an ethnicity. The proportion of ethnicities in this group is estimated to be the same as the proportion in the declared group.
Sources: en.wikipedia.org
=== ROTOR === The British radar defences were rapidly run down during the last years of the war, with many sites closed and others placed on "care and maintenance". However, immediate postwar tensions with the Soviet Union resulted in recommissioning of some wartime radars as a stopgap measure. Specific radars were remanufactured to peacetime standards of quality and reliability, which gave significant increases in range and accuracy. These rebuilt systems were the first phase of Chain Home's replacement system, ROTOR, which progressed through three phases from 1949 to 1958. It had been pointed out from the start that due to the inherent timing of the interception task, about 23 minutes was required to carry out a single interception from initial detection. If the target was a high-speed jet bomber, this required about 240 miles (390 km) initial detection range. CH, even in its upgraded form, was barely capable of this under the best conditions. The GCI radars were not even close to this, and the entire ROTOR system relied on a new radar system becoming available by 1957 at the latest. In one of the few instances of this occurring, this requirement was actually beaten, with the first AMES Type 80 systems entering service in 1954. The very last Chain Home Type 1 systems were retired in 1955 along with the wholesale demolition of most of the steel and timber towers.
=== Correlation with birth defects === Some studies show a correlation between the consumption of potatoes suffering from late blight (which increases solanine and other glycoalkaloid levels) and the incidence of spina bifida in humans. However, other studies have shown no correlation between potato consumption and the incidence of birth defects.
Newsom's first political experience came when he volunteered for Willie Brown's successful campaign for mayor in 1995. Newsom hosted a private fundraiser at his PlumpJack Café. Brown appointed Newsom to a vacant seat on the Parking and Traffic Commission in 1996, and he was later elected president of the commission. Brown appointed him to the San Francisco Board of Supervisors seat vacated by Kevin Shelley in 1997. At the time, he was the youngest member of San Francisco's board of supervisors. Newsom was sworn in by his father and pledged to bring his business experience to the board. Brown called Newsom "part of the future generation of leaders of this great city". Newsom described himself as a "social liberal and a fiscal watchdog". He was elected to a full four-year term to the board in 1998. San Francisco voters chose to abandon at-large elections to the board for the previous district system in 1999. Newsom was reelected in 2000 and 2002 to represent the second district, which includes Pacific Heights, the Marina, Cow Hollow, Sea Cliff, and Laurel Heights, which had San Francisco's highest income level and highest Republican registration. Newsom paid $500 to the San Francisco Republican Party to appear on the party's endorsement slate in 2000 while running for Supervisor. He was reelected. As a San Francisco Supervisor, Newsom gained public attention for his role in advocating reform of the city's municipal railway (Muni). He was one of two supervisors endorsed by Rescue Muni, a transit riders group, in his 1998 reelection.
Sources: en.wikipedia.org
The 82nd Division was redesignated on 13 February 1942 as Division Headquarters, 82nd Division, and ordered into active service on 25 March 1942, at Camp Claiborne, Louisiana, under the command of Major General Omar N. Bradley. The officer and enlisted cadre mostly came from the 9th Infantry Division. The enlisted men came from reception centers in the Midwest, South, and Southwest. During this period, the division brought together three officers who would ultimately steer the US Army during the following two decades: Matthew Ridgway, James M. Gavin, and Maxwell D. Taylor. Under Major General Bradley, the 82nd Division's Chief of staff was George Van Pope. On 15 August 1942, the 82nd Infantry Division, now commanded by Major General Ridgway, became the first airborne division in the history of the US Army, and was redesignated as the 82nd Airborne Division. The 82nd was selected after deliberations by the US Army General Staff because of a number of factors. It was not a Regular Army or National Guard unit, its personnel had all completed basic training, and it was stationed in an area that had good weather and flying facilities. Historian John B. Wilson wrote that "many traditionalists in those components wanted nothing to do with such an experimental force". James M. Gavin wrote that many states would refuse the conversion of their National Guard units, likely because of the additional expenses needed to maintain facilities for airborne units. The division initially consisted of the 325th, 326th and 327th Infantry Regiments, and supporting units.
In the view of UCC, "the ruling reaffirms UCC's long-held positions and finally puts to rest—both procedurally and substantively—the issues raised in the class action complaint first filed against Union Carbide in 1999 by Haseena Bi and several organisations representing the residents of Bhopal". In June 2010, seven former employees of UCIL, all Indian nationals and many in their 70s, were convicted of causing death by negligence: Keshub Mahindra, former non-executive chairman of Union Carbide India Limited; V. P. Gokhale, managing director; Kishore Kamdar, vice-president; J. Mukund, works manager; S. P. Choudhary, production manager; K. V. Shetty, plant superintendent; and S. I. Qureshi, production assistant. They were each sentenced to two years' imprisonment and fined ₹100,000 (equivalent to ₹240,000 or US$2,500 in 2026). All were released on bail shortly after the verdict. A US federal class action litigation, Sahu v. Union Carbide and Warren Anderson, was filed in 1999 under the U.S. Alien Torts Claims Act (ATCA), which provides for civil remedies for "crimes against humanity". It sought damages for personal injury, medical monitoring and injunctive relief in the form of clean-up of the drinking water supplies for residential areas near the Bhopal plant. The lawsuit was dismissed in 2012 and the subsequent appeal was denied. Warren Anderson, then 92 years old, died on 29 September 2014. On 14 March 2023, Indian Supreme Court dismissed curative petition for enhanced compensation.
C3Cl4 + AlCl3 → [C3Cl3]+AlCl−4 Tetrachlorocyclopropene can be converted to tris(tert-butyldimethylsilyl)cyclopropene. Hydride abstraction with nitrosonium tetrafluoroborate yields the trisilyl-substituted cyclopropenium cation.
Sources: en.wikipedia.org
It is a synthetic cyclic peptide that activates melanocortin receptors. It is given by injection and was approved in the United States in 2019 for a specific low-desire diagnosis in premenopausal women. It is not a hormonal therapy.
Earlier approaches were largely hormonal or psychological in focus, whereas this compound acts on central melanocortin signalling. It is not a vasodilator and does not share the mechanism of phosphodiesterase inhibitors. Head-to-head comparative data are limited.
Placebo responses in desire trials are large, so the average drug-placebo separation is small. Reporting therefore relies on validated questionnaires with statistical ranges. Individual responses vary widely.
Storage at -20 °C or below is standard for long-term stability. Desiccant and sealed containers limit moisture exposure. Solutions are prepared only when needed.